MedTrace Logo

Eight Week Study of Treatment With DFD-07 for Actinic Keratosis of the Face and Scalp

NCT02654717 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 111

Last updated 2020-03-17

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to see how well DFD-07 works in treating actinic keratosis on the face and scalp during 8 weeks of treatment. The study will also look at any unwanted effects of the study drug.

Conditions

  • Actinic Keratosis

Interventions

DRUG

DFD-07 Cream

DRUG

Placebo Cream

Sponsors & Collaborators

  • Promius Pharma, LLC

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2016-08-31
Completion
2016-08-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02654717 on ClinicalTrials.gov